Report Detail
Global Calcium Channel Blocker Market Growth 2019-2024
- RnM2953078 |
- 15 February, 2019 |
- Global |
- 137 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
The demand of Calcium Channel Blocker is concentrated in developed areas like USA and Europe. In 2016, the consumption of Calcium Channel Blocker in USA was 26.78%, ahead of other regions. Other regions also enjoy the major market share in global region.
In the future, the Calcium Channel Blocker will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the monopoly phenomenon will be weaken. The installed rate in the commercial vehicle will increase.
According to this study, over the next five years the Calcium Channel Blocker market will register a 1.5% CAGR in terms of revenue, the global market size will reach US$ 78 million by 2024, from US$ 72 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Calcium Channel Blocker business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Calcium Channel Blocker market by product type, application, key manufacturers and key regions and countries.
This study considers the Calcium Channel Blocker value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Dihydropyridine
Diltiazem
Verapamil
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Calcium Channel Blocker consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Calcium Channel Blocker market by identifying its various subsegments.
Focuses on the key global Calcium Channel Blocker manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Calcium Channel Blocker with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Calcium Channel Blocker submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Calcium Channel Blocker Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Calcium Channel Blocker Consumption 2014-2024
- 2.1.2 Calcium Channel Blocker Consumption CAGR by Region
- 2.2 Calcium Channel Blocker Segment by Type
- 2.2.1 Dihydropyridine
- 2.2.2 Diltiazem
- 2.2.3 Verapamil
- 2.2.4 Others
- 2.3 Calcium Channel Blocker Consumption by Type
- 2.3.1 Global Calcium Channel Blocker Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Calcium Channel Blocker Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Calcium Channel Blocker Sale Price by Type (2014-2019)
- 2.4 Calcium Channel Blocker Segment by Application
- 2.4.1 Hypertension
- 2.4.2 Coronary Artery Disease
- 2.4.3 Arrhythmia
- 2.4.4 Cardiomyopathy
- 2.5 Calcium Channel Blocker Consumption by Application
- 2.5.1 Global Calcium Channel Blocker Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Calcium Channel Blocker Value and Market Share by Application (2014-2019)
- 2.5.3 Global Calcium Channel Blocker Sale Price by Application (2014-2019)
3 Global Calcium Channel Blocker by Players
- 3.1 Global Calcium Channel Blocker Sales Market Share by Players
- 3.1.1 Global Calcium Channel Blocker Sales by Players (2017-2019)
- 3.1.2 Global Calcium Channel Blocker Sales Market Share by Players (2017-2019)
- 3.2 Global Calcium Channel Blocker Revenue Market Share by Players
- 3.2.1 Global Calcium Channel Blocker Revenue by Players (2017-2019)
- 3.2.2 Global Calcium Channel Blocker Revenue Market Share by Players (2017-2019)
- 3.3 Global Calcium Channel Blocker Sale Price by Players
- 3.4 Global Calcium Channel Blocker Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Calcium Channel Blocker Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Calcium Channel Blocker Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Calcium Channel Blocker by Regions
- 4.1 Calcium Channel Blocker by Regions
- 4.1.1 Global Calcium Channel Blocker Consumption by Regions
- 4.1.2 Global Calcium Channel Blocker Value by Regions
- 4.2 Americas Calcium Channel Blocker Consumption Growth
- 4.3 APAC Calcium Channel Blocker Consumption Growth
- 4.4 Europe Calcium Channel Blocker Consumption Growth
- 4.5 Middle East & Africa Calcium Channel Blocker Consumption Growth
5 Americas
- 5.1 Americas Calcium Channel Blocker Consumption by Countries
- 5.1.1 Americas Calcium Channel Blocker Consumption by Countries (2014-2019)
- 5.1.2 Americas Calcium Channel Blocker Value by Countries (2014-2019)
- 5.2 Americas Calcium Channel Blocker Consumption by Type
- 5.3 Americas Calcium Channel Blocker Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Calcium Channel Blocker Consumption by Countries
- 6.1.1 APAC Calcium Channel Blocker Consumption by Countries (2014-2019)
- 6.1.2 APAC Calcium Channel Blocker Value by Countries (2014-2019)
- 6.2 APAC Calcium Channel Blocker Consumption by Type
- 6.3 APAC Calcium Channel Blocker Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Calcium Channel Blocker by Countries
- 7.1.1 Europe Calcium Channel Blocker Consumption by Countries (2014-2019)
- 7.1.2 Europe Calcium Channel Blocker Value by Countries (2014-2019)
- 7.2 Europe Calcium Channel Blocker Consumption by Type
- 7.3 Europe Calcium Channel Blocker Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Calcium Channel Blocker by Countries
- 8.1.1 Middle East & Africa Calcium Channel Blocker Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Calcium Channel Blocker Value by Countries (2014-2019)
- 8.2 Middle East & Africa Calcium Channel Blocker Consumption by Type
- 8.3 Middle East & Africa Calcium Channel Blocker Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Calcium Channel Blocker Distributors
- 10.3 Calcium Channel Blocker Customer
11 Global Calcium Channel Blocker Market Forecast
- 11.1 Global Calcium Channel Blocker Consumption Forecast (2019-2024)
- 11.2 Global Calcium Channel Blocker Forecast by Regions
- 11.2.1 Global Calcium Channel Blocker Forecast by Regions (2019-2024)
- 11.2.2 Global Calcium Channel Blocker Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Calcium Channel Blocker Forecast by Type
- 11.8 Global Calcium Channel Blocker Forecast by Application
12 Key Players Analysis
- 12.1 Pfizer
- 12.1.1 Company Details
- 12.1.2 Calcium Channel Blocker Product Offered
- 12.1.3 Pfizer Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Pfizer News
- 12.2 Aventis
- 12.2.1 Company Details
- 12.2.2 Calcium Channel Blocker Product Offered
- 12.2.3 Aventis Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Aventis News
- 12.3 Searle
- 12.3.1 Company Details
- 12.3.2 Calcium Channel Blocker Product Offered
- 12.3.3 Searle Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Searle News
- 12.4 Bayer
- 12.4.1 Company Details
- 12.4.2 Calcium Channel Blocker Product Offered
- 12.4.3 Bayer Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Bayer News
- 12.5 AstraZeneca
- 12.5.1 Company Details
- 12.5.2 Calcium Channel Blocker Product Offered
- 12.5.3 AstraZeneca Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 AstraZeneca News
- 12.6 Knoll Pharmaceuticals
- 12.6.1 Company Details
- 12.6.2 Calcium Channel Blocker Product Offered
- 12.6.3 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Knoll Pharmaceuticals News
- 12.7 Wyeth-Ayerst
- 12.7.1 Company Details
- 12.7.2 Calcium Channel Blocker Product Offered
- 12.7.3 Wyeth-Ayerst Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Wyeth-Ayerst News
- 12.8 AstraZeneca
- 12.8.1 Company Details
- 12.8.2 Calcium Channel Blocker Product Offered
- 12.8.3 AstraZeneca Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 AstraZeneca News
- 12.9 Novartis
- 12.9.1 Company Details
- 12.9.2 Calcium Channel Blocker Product Offered
- 12.9.3 Novartis Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Novartis News
- 12.10 Sanofi
- 12.10.1 Company Details
- 12.10.2 Calcium Channel Blocker Product Offered
- 12.10.3 Sanofi Calcium Channel Blocker Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Sanofi News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Calcium Channel Blocker . Industry analysis & Market Report on Calcium Channel Blocker is a syndicated market report, published as Global Calcium Channel Blocker Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Calcium Channel Blocker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
